Snowflake director sells 300K shares around $330
Rhea-AI Filing Summary
Snowflake Inc. (SNOW) director Frank Slootman reported exercising stock options for 300,000 shares of common stock at an exercise price of $8.88 per share on September 18 and 21, 2026, and selling 300,000 shares in multiple open-market transactions at prices around the low-to-mid $330s. These exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025, and some additional shares are held indirectly through various trusts for which he or his spouse serves as trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 300,000 shares ($97.68M approx. pre-tax spread)
Exercise and Sale
27 txns
Insider
Slootman Frank
Role
Director
Sold
300,000 shs ($100.35M)
Approx. gross sale proceeds
$100.35M
Approx. exercise cost
$2.66M
Approx. pre-tax spread
$97.68M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F25 | 102,791 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 102,791 | $8.88 | $913K |
| Sale | Common Stock F1, F10, F2 | 1,936 | $330.165 | $639K |
| Sale | Common Stock F1, F11, F2 | 2,268 | $331.181 | $751K |
| Sale | Common Stock F1, F12, F2 | 6,671 | $332.261 | $2.22M |
| Sale | Common Stock F1, F13, F2 | 5,740 | $333.465 | $1.91M |
| Sale | Common Stock F1, F14, F2 | 25,159 | $334.349 | $8.41M |
| Sale | Common Stock F1, F15, F2 | 25,268 | $335.081 | $8.47M |
| Sale | Common Stock F1, F16, F2 | 9,843 | $336.293 | $3.31M |
| Sale | Common Stock F1, F17, F2 | 15,867 | $337.237 | $5.35M |
| Sale | Common Stock F1, F18, F2 | 7,529 | $338.121 | $2.55M |
| Sale | Common Stock F1, F19, F2 | 2,510 | $338.994 | $851K |
| Exercise | Stock Option (Right to Buy) F1, F25 | 197,209 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 197,209 | $8.88 | $1.75M |
| Sale | Common Stock F1, F3, F2 | 15,187 | $331.352 | $5.03M |
| Sale | Common Stock F1, F4, F2 | 23,507 | $332.189 | $7.81M |
| Sale | Common Stock F1, F5, F2 | 79,366 | $333.269 | $26.45M |
| Sale | Common Stock F1, F6, F2 | 42,009 | $334.24 | $14.04M |
| Sale | Common Stock F1, F7, F2 | 2,841 | $335.228 | $952K |
| Sale | Common Stock F1, F8, F2 | 4,097 | $336.107 | $1.38M |
| Sale | Common Stock F1, F2 | 102 | $337.05 | $34K |
| Sale | Common Stock F1, F9, F2 | 30,100 | $338.609 | $10.19M |
| holding | Common Stock F20 | -- | -- | -- |
| holding | Common Stock F21 | -- | -- | -- |
| holding | Common Stock F22 | -- | -- | -- |
| holding | Common Stock F23 | -- | -- | -- |
| holding | Common Stock F24 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 4,136,655 contracts (Direct);
Common Stock — 19,024 shares (Direct);
Common Stock — 210,029 shares (Indirect, Trust)
Footnotes (25)
- F1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
- F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.745 to $331.740, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.760 to $332.750, inclusive.
- F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.770 to $333.760, inclusive.
- F6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.780 to $334.775, inclusive.
- F7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.785 to $335.770, inclusive.
- F8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.800 to $336.480, inclusive.
- F9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.250 to $338.610, inclusive.
- F10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $329.540 to $330.510, inclusive.
- F11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.705 to $331.520, inclusive.
- F12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.730 to $332.725, inclusive.
- F13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.750 to $333.740, inclusive.
- F14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.750 to $334.745, inclusive.
- F15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.750 to $335.740, inclusive.
- F16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.765 to $336.750, inclusive.
- F17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $336.780 to $337.750, inclusive.
- F18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $337.780 to $338.720, inclusive.
- F19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.800 to $339.340, inclusive.
- F20. The shares are held by the Slootman Living Trust dated 9/8/1999 for which the Reporting Person is a trustee.
- F21. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
- F22. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
- F23. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
- F24. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
- F25. The stock option is fully vested.
Key Figures
Options exercised: 300,000 shares
Exercise price: $8.88 per share
Shares sold: 300,000 shares
+4 more
7 metrics
Options exercised
300,000 shares
Stock options for Snowflake common stock exercised on September 18 and 21, 2026
Exercise price
$8.88 per share
Exercise price of stock options converted into Snowflake common stock
Shares sold
300,000 shares
Total Snowflake common shares sold in open-market transactions reported in this Form 4
Sample sale price
$331.352 per share
Weighted-average price for a 15,187-share sale on September 18, 2026
Highest reported sale price example
$338.609 per share
Weighted-average price for a 30,100-share sale on September 18, 2026
Rule 10b5-1 plan adoption date
September 19, 2025
Date the trading plan governing these exercises and sales was adopted
Option expiration date
May 28, 2029
Expiration date for the fully vested stock options that were exercised
Key Terms
Rule 10b5-1 trading plan, weighted-average price, restricted stock units, Grantor Retained Annuity Trust, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The exercises and sales reported ... were effected pursuant to a 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
restricted stock units financial
"Includes shares to be issued in connection with the vesting of one or more restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Grantor Retained Annuity Trust financial
"The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
Living Trust financial
"The shares are held by the Slootman Living Trust dated 9/8/1999"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Snowflake (SNOW) director Frank Slootman report in this Form 4?
He reported exercising options for 300,000 SNOW shares at $8.88 per share and selling 300,000 shares of common stock in multiple open-market transactions in the low-to-mid $330s on September 18 and 21, 2026, under a Rule 10b5-1 trading plan.
What stock options did Frank Slootman exercise in Snowflake (SNOW)?
He exercised stock options covering 300,000 shares of Snowflake common stock at an exercise price of $8.88 per share. The options are described as fully vested and carry an expiration date of May 28, 2029 in the option-related entries.
Were Frank Slootman’s SNOW transactions made under a Rule 10b5-1 plan?
Yes. A footnote states that the exercises and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by Frank Slootman on September 19, 2025, and the filing indicates the Rule 10b5-1 checkbox as affirmed.
What are the key dates of the Snowflake (SNOW) insider transactions?
The reported option exercises and related sales occurred on September 18, 2026 and September 21, 2026. The Rule 10b5-1 trading plan under which these were effected was adopted on September 19, 2025, and the option expiration date is May 28, 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.